US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Ocular Therapeutix

8.10

0.0000

Post-market: 8.170.0700+0.86%19:59 EDT

Volume:3.65M

Turnover:29.17M

Market Cap:1.76B

PE:-5.70

High:8.19

Open:8.05

Low:7.79

Close:8.10

52wk High:16.44

52wk Low:5.80

Shares:217.69M

Float Shares:191.00M

Volume Ratio:1.13

T/O Rate:1.91%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.4203

EPS(LYR):-1.4203

ROE:-54.85%

ROA:-26.66%

PB:2.69

PE(LYR):-5.70

Loading ...

Overview Company News Filings

Ocular Therapeutix: Axpaxli Met Its Week 52 Durability Assessment With High Statistical Significance

THOMSON REUTERS

Ocular Therapeutix: Superiority Primary Endpoint Met With 74.1% of Subjects in Axpaxli Arm Maintaining Vision at Week 36

THOMSON REUTERS

Assessing Ocular Therapeutix (OCUL) Valuation After Wider Losses And Potential Share Dilution

Simply Wall St.

Ocular Therapeutix to Release Topline Data for Macular Degeneration Treatment

Ocular Therapeutix to Announce Topline Data for Phase 3 SOL-1 Trial in Wet AMD

Ocular Therapeutix gewährt neuen Mitarbeitern Aktienanreize gemäß Nasdaq-Regel

Ocular Therapeutix Grants Inducement Equity Awards to New Employees

Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Analysts Conflicted on These Healthcare Names: Illumina (ILMN) and Ocular Therapeutix (OCUL)

Regulatory Turbulence Threatens Ocular Therapeutix: FDA Disruptions and Global Delays Raise Approval and Funding Risks

Ocular Therapeutix's Recent Stock Weakness Presents Buying Opportunity, RBC Says

MT Newswires Live

Analysts Offer Insights on Healthcare Companies: Cabaletta Bio (CABA) and Ocular Therapeutix (OCUL)

Ocular Therapeutix Q4 EPS $(0.29) Beats $(0.32) Estimate, Sales $13.250M Miss $16.128M Estimate

Ocular Therapeutix Q4 revenue falls 22.4% yr/yr

Earnings Flash (OCUL) Ocular Therapeutix Posts Q4 Loss $0.29 a Share, vs. FactSet Est of $0.32 Loss

MT Newswires Live

Ocular Therapeutix to Present Phase 3 SOL-1 Wet AMD Trial Results at Macula Society Meeting

Ocular Therapeutix Inc. meldet für das Gesamtjahr 2025 einen Anstieg des Eigenkapitals auf 654,31 Mio. USD um 107 Prozent

BRIEF-Ocular Therapeutix Q4 EPS USD -0.29

Ocular Therapeutix™ Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights

THOMSON REUTERS

Ocular Therapeutix Q4 Product Revenue USD 13.25 Million

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/OCUL/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OCUL","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OCUL\",,,,,undefined,":{"symbol":"OCUL","market":"US","secType":"STK","nameCN":"Ocular Therapeutix","latestPrice":8.1,"timestamp":1774382400000,"preClose":8.1,"halted":0,"volume":3646313,"hourTrading":{"tag":"盘后","latestPrice":8.17,"preClose":8.1,"latestTime":"19:59 EDT","volume":74512,"amount":603669.5546,"timestamp":1774396777659,"change":0.07,"changeRate":0.008642,"amplitude":0.012346},"delay":0,"changeRate":0,"floatShares":191000000,"shares":217691779,"eps":-1.420299,"marketStatus":"Closed","change":0,"latestTime":"03-24 16:00:00 EDT","open":8.05,"high":8.19,"low":7.785,"amount":29165407.9129512,"amplitude":0.05,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-1.420299,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1774425600000},"marketStatusCode":5,"adr":0,"adrRate":0,"listingDate":1406260800000,"exchange":"NASDAQ","adjPreClose":8.1,"preHourTrading":{"tag":"盘前","latestPrice":8.05,"preClose":8.1,"latestTime":"09:28 EDT","volume":1161,"amount":9434.388168,"timestamp":1774358880052,"change":-0.05,"changeRate":-0.006173,"amplitude":0.011111},"postHourTrading":{"tag":"盘后","latestPrice":8.17,"preClose":8.1,"latestTime":"19:59 EDT","volume":74512,"amount":603669.5546,"timestamp":1774396777659,"change":0.07,"changeRate":0.008642,"amplitude":0.012346},"volumeRatio":1.125075,"impliedVol":0.7462,"impliedVolPercentile":0.4622},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OCUL\",,,,,undefined,":{"symbol":"OCUL","floatShares":191000000,"roa":"-26.66%","roe":"-54.85%","lyrEps":-1.420299,"volumeRatio":1.125075,"shares":217691779,"dividePrice":0,"high":8.19,"amplitude":0.05,"preClose":8.1,"low":7.785,"week52Low":5.8,"pbRate":"2.69","psRate":"33.94","week52High":16.44,"institutionHeld":0,"latestPrice":8.1,"eps":-1.420299,"divideRate":0,"volume":3646313,"delay":0,"ttmEps":-1.420299,"open":8.05,"prevYearClose":12.14,"prevWeekClose":8.18,"prevMonthClose":8.94,"prevQuarterClose":12.14,"fiveDayClose":8.68,"twentyDayClose":8.955,"sixtyDayClose":12.71},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OCUL\",params:#limit:5,,,undefined,":[{"date":"2026-02-05","symbol":"OCUL","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1770282000000,"name":null,"time":"Pre-Market","dateTimestamp":1770267600000,"actualEps":null},{"market":"US","date":"2025-11-04","symbol":"OCUL","fiscalQuarterEnding":"2025/09","expectedEps":-0.39,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1762232400000,"reportTimeType":"pre","actualEps":-0.37},{"market":"US","date":"2025-08-05","symbol":"OCUL","fiscalQuarterEnding":"2025/06","expectedEps":-0.35,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1754366400000,"reportTimeType":"pre","actualEps":-0.39},{"market":"US","date":"2025-05-05","symbol":"OCUL","fiscalQuarterEnding":"2025/03","expectedEps":-0.29,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1746417600000,"reportTimeType":"pre","actualEps":-0.37},{"market":"US","date":"2025-03-03","symbol":"OCUL","fiscalQuarterEnding":"2024/12","expectedEps":-0.24,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1740978000000,"reportTimeType":"pre","actualEps":-0.29}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OCUL\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OCUL\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.3846,"buy":0.6154,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.6154,"analysts":13,"updateTime":1757995200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/OCUL\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"OCUL","date":"2026-03-23","current":-5.703025,"percent":0.653045,"low":-65.357579,"twenty":-10.827953,"median":-7.87674,"eighty":-5.487961,"high":-2.025529,"avg":-9.898393,"sd":9.768088,"marketCap":1780718752},"quantilePoints":[{"date":"2021-03-26","current":-8.294369,"twenty":-6.565241,"median":-4.20367,"eighty":-3.162843,"marketCap":1290902350},{"date":"2021-04-01","current":-8.509426,"twenty":-6.565241,"median":-4.20367,"eighty":-3.162843,"marketCap":1324373006},{"date":"2021-04-09","current":-8.069536,"twenty":-6.559034,"median":-4.20367,"eighty":-3.161729,"marketCap":1255910301},{"date":"2021-04-16","current":-7.783555,"twenty":-6.559034,"median":-4.20367,"eighty":-3.161729,"marketCap":1211401321},{"date":"2021-04-23","current":-7.570474,"twenty":-6.559034,"median":-4.20367,"eighty":-3.161729,"marketCap":1178238353},{"date":"2021-04-30","current":-9.009793,"twenty":-6.559034,"median":-4.20367,"eighty":-3.161729,"marketCap":1402248154},{"date":"2021-05-07","current":-9.463494,"twenty":-6.559034,"median":-4.20367,"eighty":-3.161729,"marketCap":1239746056},{"date":"2021-05-14","current":-8.624882,"twenty":-6.559034,"median":-4.20367,"eighty":-3.161729,"marketCap":1129885482},{"date":"2021-05-21","current":-8.007572,"twenty":-6.559034,"median":-4.20367,"eighty":-3.161729,"marketCap":1049015893},{"date":"2021-05-28","current":-8.47929,"twenty":-6.559034,"median":-4.20367,"eighty":-3.161729,"marketCap":1110812466},{"date":"2021-06-04","current":-8.444348,"twenty":-6.559034,"median":-4.20367,"eighty":-3.161729,"marketCap":1106234942},{"date":"2021-06-11","current":-8.41523,"twenty":-6.591428,"median":-4.20367,"eighty":-3.161729,"marketCap":1102420339},{"date":"2021-06-18","current":-7.867803,"twenty":-6.623312,"median":-4.20367,"eighty":-3.161729,"marketCap":1030705798},{"date":"2021-06-25","current":-8.205577,"twenty":-6.676056,"median":-4.20367,"eighty":-3.161729,"marketCap":1074955195},{"date":"2021-07-02","current":-7.955158,"twenty":-6.735857,"median":-4.208509,"eighty":-3.161729,"marketCap":1042149607},{"date":"2021-07-09","current":-7.710563,"twenty":-6.771617,"median":-4.208509,"eighty":-3.161729,"marketCap":1010106940},{"date":"2021-07-16","current":-7.110724,"twenty":-6.82923,"median":-4.21345,"eighty":-3.161729,"marketCap":931526113},{"date":"2021-07-23","current":-7.192255,"twenty":-6.860803,"median":-4.216745,"eighty":-3.161729,"marketCap":942207002},{"date":"2021-07-30","current":-6.411881,"twenty":-6.860803,"median":-4.22639,"eighty":-3.161729,"marketCap":839975635},{"date":"2021-08-06","current":-6.132344,"twenty":-6.860803,"median":-4.229028,"eighty":-3.161729,"marketCap":803355444},{"date":"2021-08-13","current":-8.006843,"twenty":-6.889323,"median":-4.229028,"eighty":-3.161729,"marketCap":824032294},{"date":"2021-08-20","current":-7.448746,"twenty":-6.943547,"median":-4.229028,"eighty":-3.161729,"marketCap":766595099},{"date":"2021-08-27","current":-8.192876,"twenty":-7.020059,"median":-4.229028,"eighty":-3.161729,"marketCap":843178026},{"date":"2021-09-03","current":-8.125904,"twenty":-7.067231,"median":-4.229028,"eighty":-3.161729,"marketCap":836285562},{"date":"2021-09-10","current":-8.088698,"twenty":-7.108368,"median":-4.229028,"eighty":-3.161729,"marketCap":832456416},{"date":"2021-09-17","current":-7.850576,"twenty":-7.126844,"median":-4.229028,"eighty":-3.161729,"marketCap":807949879},{"date":"2021-09-24","current":-7.805928,"twenty":-7.166094,"median":-4.229028,"eighty":-3.161729,"marketCap":803354904},{"date":"2021-10-01","current":-7.716633,"twenty":-7.199885,"median":-4.229028,"eighty":-3.161729,"marketCap":794164952},{"date":"2021-10-08","current":-7.255272,"twenty":-7.221044,"median":-4.229028,"eighty":-3.161729,"marketCap":746683538},{"date":"2021-10-15","current":-8.326819,"twenty":-7.255307,"median":-4.229028,"eighty":-3.161729,"marketCap":856962953},{"date":"2021-10-22","current":-5.141941,"twenty":-7.285114,"median":-4.229028,"eighty":-3.161729,"marketCap":529188025},{"date":"2021-10-29","current":-4.941026,"twenty":-7.285114,"median":-4.229028,"eighty":-3.161729,"marketCap":508510635},{"date":"2021-11-05","current":-5.186589,"twenty":-7.285114,"median":-4.240574,"eighty":-3.161729,"marketCap":533783001},{"date":"2021-11-12","current":-6.04623,"twenty":-7.285114,"median":-4.242896,"eighty":-3.161729,"marketCap":533972766},{"date":"2021-11-19","current":-5.803339,"twenty":-7.284102,"median":-4.242896,"eighty":-3.161729,"marketCap":512521923},{"date":"2021-11-26","current":-5.67322,"twenty":-7.270563,"median":-4.242896,"eighty":-3.161729,"marketCap":501030400},{"date":"2021-12-03","current":-5.343583,"twenty":-7.270563,"median":-4.242896,"eighty":-3.161729,"marketCap":471918542},{"date":"2021-12-10","current":-5.681894,"twenty":-7.270563,"median":-4.242896,"eighty":-3.161729,"marketCap":501796502},{"date":"2021-12-17","current":-6.063579,"twenty":-7.270563,"median":-4.242896,"eighty":-3.161729,"marketCap":535504969},{"date":"2021-12-23","current":-6.263096,"twenty":-7.270563,"median":-4.242896,"eighty":-3.161729,"marketCap":553125304},{"date":"2021-12-31","current":-6.04623,"twenty":-7.270563,"median":-4.242896,"eighty":-3.161729,"marketCap":533972766},{"date":"2022-01-07","current":-5.586473,"twenty":-7.266258,"median":-4.247437,"eighty":-3.162843,"marketCap":493369385},{"date":"2022-01-14","current":-5.378282,"twenty":-7.266258,"median":-4.247437,"eighty":-3.162843,"marketCap":474982948},{"date":"2022-01-21","current":-4.771056,"twenty":-7.266258,"median":-4.247437,"eighty":-3.162843,"marketCap":421355841},{"date":"2022-01-28","current":-4.640937,"twenty":-7.266258,"median":-4.247437,"eighty":-3.162843,"marketCap":409864318},{"date":"2022-02-04","current":-4.745032,"twenty":-7.266258,"median":-4.247437,"eighty":-3.162843,"marketCap":419057536},{"date":"2022-02-11","current":-4.736358,"twenty":-7.266258,"median":-4.247437,"eighty":-3.162843,"marketCap":418291435},{"date":"2022-02-18","current":-4.250577,"twenty":-7.249318,"median":-4.246736,"eighty":-3.162843,"marketCap":375389749},{"date":"2022-02-25","current":-4.788406,"twenty":-7.249318,"median":-4.241898,"eighty":-3.162843,"marketCap":422888044},{"date":"2022-03-04","current":-57.744241,"twenty":-7.285075,"median":-4.241898,"eighty":-3.162843,"marketCap":378398008},{"date":"2022-03-11","current":-62.195115,"twenty":-7.340609,"median":-4.241898,"eighty":-3.162843,"marketCap":407564589},{"date":"2022-03-18","current":-61.84373,"twenty":-7.362814,"median":-4.241898,"eighty":-3.162843,"marketCap":405261964},{"date":"2022-03-25","current":-59.735421,"twenty":-7.406344,"median":-4.241898,"eighty":-3.162843,"marketCap":391446216},{"date":"2022-04-01","current":-56.807214,"twenty":-7.449214,"median":-4.241898,"eighty":-3.162843,"marketCap":372257676},{"date":"2022-04-08","current":-54.816034,"twenty":-7.466341,"median":-4.241898,"eighty":-3.162843,"marketCap":359209468},{"date":"2022-04-14","current":-51.302185,"twenty":-7.515877,"median":-4.241898,"eighty":-3.162843,"marketCap":336183220},{"date":"2022-04-22","current":-42.868949,"twenty":-7.572917,"median":-4.241898,"eighty":-3.162843,"marketCap":280920225},{"date":"2022-04-29","current":-41.814795,"twenty":-7.665046,"median":-4.241898,"eighty":-3.162843,"marketCap":274012351},{"date":"2022-05-06","current":-40.6464,"twenty":-7.700971,"median":-4.241898,"eighty":-3.162843,"marketCap":266355860},{"date":"2022-05-13","current":-11.332892,"twenty":-7.733621,"median":-4.241898,"eighty":-3.162843,"marketCap":251771533},{"date":"2022-05-20","current":-11.574753,"twenty":-7.788471,"median":-4.241898,"eighty":-3.162843,"marketCap":257144706},{"date":"2022-05-27","current":-11.021929,"twenty":-7.811217,"median":-4.241898,"eighty":-3.162843,"marketCap":244863168},{"date":"2022-06-03","current":-10.849171,"twenty":-7.856528,"median":-4.241898,"eighty":-3.162843,"marketCap":241025187},{"date":"2022-06-10","current":-12.749504,"twenty":-7.880577,"median":-4.241898,"eighty":-3.162843,"marketCap":283242975},{"date":"2022-06-17","current":-12.922261,"twenty":-7.936523,"median":-4.241898,"eighty":-3.162843,"marketCap":287080956},{"date":"2022-06-24","current":-13.786049,"twenty":-7.987496,"median":-4.240899,"eighty":-3.161729,"marketCap":306270859},{"date":"2022-07-01","current":-14.131564,"twenty":-8.024062,"median":-4.240899,"eighty":-3.161729,"marketCap":313946821},{"date":"2022-07-08","current":-15.513624,"twenty":-8.058933,"median":-4.240899,"eighty":-3.161729,"marketCap":344650666},{"date":"2022-07-15","current":-14.9608,"twenty":-8.088698,"median":-4.240899,"eighty":-3.161729,"marketCap":332369128},{"date":"2022-07-22","current":-15.099006,"twenty":-8.134478,"median":-4.240899,"eighty":-3.161729,"marketCap":335439513},{"date":"2022-07-29","current":-15.479072,"twenty":-8.181941,"median":-4.240899,"eighty":-3.161729,"marketCap":343883070},{"date":"2022-08-05","current":-17.137544,"twenty":-8.215678,"median":-4.250577,"eighty":-3.161729,"marketCap":380727685},{"date":"2022-08-12","current":-12.977402,"twenty":-8.304373,"median":-4.275211,"eighty":-3.161729,"marketCap":421778551},{"date":"2022-08-19","current":-12.385367,"twenty":-8.35569,"median":-4.302833,"eighty":-3.161729,"marketCap":402536829},{"date":"2022-08-26","current":-12.030147,"twenty":-8.397759,"median":-4.330109,"eighty":-3.161729,"marketCap":390991796},{"date":"2022-09-02","current":-12.5985,"twenty":-8.440803,"median":-4.371283,"eighty":-3.161729,"marketCap":409463849},{"date":"2022-09-09","current":-14.161472,"twenty":-8.508816,"median":-4.37685,"eighty":-3.161729,"marketCap":460261996},{"date":"2022-09-16","current":-13.900977,"twenty":-8.602312,"median":-4.412457,"eighty":-3.161729,"marketCap":451795638},{"date":"2022-09-23","current":-12.527456,"twenty":-8.726496,"median":-4.426181,"eighty":-3.161729,"marketCap":407154842},{"date":"2022-09-30","current":-9.827777,"twenty":-8.861778,"median":-4.45363,"eighty":-3.161729,"marketCap":319412589},{"date":"2022-10-07","current":-10.254042,"twenty":-9.114761,"median":-4.525226,"eighty":-3.161729,"marketCap":333266629},{"date":"2022-10-14","current":-9.756733,"twenty":-9.354149,"median":-4.545515,"eighty":-3.161729,"marketCap":317103582},{"date":"2022-10-21","current":-8.714752,"twenty":-9.396835,"median":-4.597563,"eighty":-3.161729,"marketCap":283238151},{"date":"2022-10-28","current":-8.714752,"twenty":-9.396835,"median":-4.657209,"eighty":-3.161729,"marketCap":283238151},{"date":"2022-11-04","current":-8.288487,"twenty":-9.396835,"median":-4.714285,"eighty":-3.161729,"marketCap":269384111},{"date":"2022-11-11","current":-4.243318,"twenty":-9.396835,"median":-4.714285,"eighty":-3.161729,"marketCap":251823958},{"date":"2022-11-18","current":-3.866999,"twenty":-9.396835,"median":-4.714285,"eighty":-3.161729,"marketCap":229490947},{"date":"2022-11-25","current":-3.918905,"twenty":-9.396835,"median":-4.714285,"eighty":-3.166402,"marketCap":232571362},{"date":"2022-12-02","current":-4.061647,"twenty":-9.396835,"median":-4.714285,"eighty":-3.189035,"marketCap":241042505},{"date":"2022-12-09","current":-3.386869,"twenty":-9.396835,"median":-4.714285,"eighty":-3.193879,"marketCap":200997104},{"date":"2022-12-16","current":-3.542587,"twenty":-9.396835,"median":-4.714285,"eighty":-3.197244,"marketCap":210238351},{"date":"2022-12-23","current":-3.464728,"twenty":-9.396835,"median":-4.714285,"eighty":-3.199668,"marketCap":205617727},{"date":"2022-12-30","current":-3.646399,"twenty":-9.396835,"median":-4.714285,"eighty":-3.225948,"marketCap":216399181},{"date":"2023-01-06","current":-4.788331,"twenty":-9.396835,"median":-4.72126,"eighty":-3.244829,"marketCap":284168320},{"date":"2023-01-13","current":-5.190603,"twenty":-9.396835,"median":-4.727683,"eighty":-3.261462,"marketCap":308041540},{"date":"2023-01-20","current":-5.320368,"twenty":-9.396835,"median":-4.745032,"eighty":-3.290783,"marketCap":315742578},{"date":"2023-01-27","current":-5.034885,"twenty":-9.396835,"median":-4.773486,"eighty":-3.304947,"marketCap":298800293},{"date":"2023-02-03","current":-5.605851,"twenty":-9.396835,"median":-4.786157,"eighty":-3.313433,"marketCap":332684863},{"date":"2023-02-10","current":-5.021909,"twenty":-9.396835,"median":-4.801308,"eighty":-3.335884,"marketCap":298030189},{"date":"2023-02-17","current":-8.136271,"twenty":-9.396835,"median":-4.837745,"eighty":-3.359534,"marketCap":482855113},{"date":"2023-02-24","current":-7.682093,"twenty":-9.396835,"median":-4.869154,"eighty":-3.374399,"marketCap":455901479},{"date":"2023-03-03","current":-7.669116,"twenty":-9.396835,"median":-4.883827,"eighty":-3.384317,"marketCap":455131375},{"date":"2023-03-10","current":-5.313628,"twenty":-9.396835,"median":-4.901176,"eighty":-3.384317,"marketCap":377469482},{"date":"2023-03-17","current":-5.411826,"twenty":-9.396835,"median":-4.920363,"eighty":-3.384317,"marketCap":384445304},{"date":"2023-03-24","current":-5.368182,"twenty":-9.396835,"median":-4.941026,"eighty":-3.384317,"marketCap":381344939},{"date":"2023-03-31","current":-5.750065,"twenty":-9.394491,"median":-4.967452,"eighty":-3.384544,"marketCap":408473136},{"date":"2023-04-06","current":-5.368182,"twenty":-9.394491,"median":-5.006377,"eighty":-3.384544,"marketCap":381344939},{"date":"2023-04-14","current":-5.880997,"twenty":-9.396835,"median":-5.030322,"eighty":-3.384317,"marketCap":417774232},{"date":"2023-04-21","current":-6.241058,"twenty":-9.396835,"median":-5.03664,"eighty":-3.384317,"marketCap":443352246},{"date":"2023-04-28","current":-6.557475,"twenty":-9.396835,"median":-5.073815,"eighty":-3.384317,"marketCap":465829895},{"date":"2023-05-05","current":-6.646015,"twenty":-9.396835,"median":-5.092018,"eighty":-3.384317,"marketCap":472119588},{"date":"2023-05-12","current":-5.455484,"twenty":-9.396835,"median":-5.131977,"eighty":-3.384317,"marketCap":484523387},{"date":"2023-05-19","current":-5.560296,"twenty":-9.396835,"median":-5.152917,"eighty":-3.384317,"marketCap":493832122},{"date":"2023-05-26","current":-5.44682,"twenty":-9.396835,"median":-5.189636,"eighty":-3.384317,"marketCap":483753915},{"date":"2023-06-01","current":-5.586483,"twenty":-9.396835,"median":-5.194225,"eighty":-3.384317,"marketCap":496157862},{"date":"2023-06-09","current":-6.642677,"twenty":-9.39918,"median":-5.235535,"eighty":-3.384091,"marketCap":589962708},{"date":"2023-06-16","current":-4.338253,"twenty":-9.39918,"median":-5.255258,"eighty":-3.384091,"marketCap":385297590},{"date":"2023-06-23","current":-4.015284,"twenty":-9.401524,"median":-5.256955,"eighty":-3.383864,"marketCap":356613463},{"date":"2023-06-30","current":-4.425542,"twenty":-9.403869,"median":-5.262699,"eighty":-3.383637,"marketCap":393050056},{"date":"2023-07-07","current":-4.233506,"twenty":-9.403869,"median":-5.262699,"eighty":-3.383637,"marketCap":375994630},{"date":"2023-07-14","current":-4.024013,"twenty":-9.403869,"median":-5.262699,"eighty":-3.383637,"marketCap":357388710},{"date":"2023-07-21","current":-3.936724,"twenty":-9.403869,"median":-5.262699,"eighty":-3.383637,"marketCap":349636243},{"date":"2023-07-28","current":-3.762147,"twenty":-9.403869,"median":-5.262699,"eighty":-3.384771,"marketCap":334131310},{"date":"2023-08-04","current":-3.849436,"twenty":-9.403869,"median":-5.262699,"eighty":-3.392505,"marketCap":341883777},{"date":"2023-08-11","current":-3.412339,"twenty":-9.403869,"median":-5.262699,"eighty":-3.399374,"marketCap":309601476},{"date":"2023-08-18","current":-3.771072,"twenty":-9.403869,"median":-5.262699,"eighty":-3.399374,"marketCap":342149324},{"date":"2023-08-25","current":-3.289844,"twenty":-9.403869,"median":-5.262699,"eighty":-3.391505,"marketCap":298487577},{"date":"2023-09-01","current":-3.307344,"twenty":-9.403869,"median":-5.262699,"eighty":-3.380757,"marketCap":300075277},{"date":"2023-09-08","current":-3.351091,"twenty":-9.403869,"median":-5.262699,"eighty":-3.375768,"marketCap":304044527},{"date":"2023-09-15","current":-3.158601,"twenty":-9.403869,"median":-5.262699,"eighty":-3.368591,"marketCap":286579828},{"date":"2023-09-22","current":-2.852365,"twenty":-9.403869,"median":-5.262699,"eighty":-3.351091,"marketCap":258795080},{"date":"2023-09-29","current":-2.791118,"twenty":-9.403869,"median":-5.262699,"eighty":-3.321084,"marketCap":253238130},{"date":"2023-10-06","current":-2.607377,"twenty":-9.403869,"median":-5.262699,"eighty":-3.307344,"marketCap":236567282},{"date":"2023-10-13","current":-2.213645,"twenty":-9.403869,"median":-5.262699,"eighty":-3.299204,"marketCap":200844034},{"date":"2023-10-20","current":-2.025529,"twenty":-9.403869,"median":-5.262699,"eighty":-3.278629,"marketCap":183776261},{"date":"2023-10-27","current":-2.152398,"twenty":-9.439644,"median":-5.283326,"eighty":-3.260219,"marketCap":195287085},{"date":"2023-11-03","current":-2.861115,"twenty":-9.439644,"median":-5.283326,"eighty":-3.241754,"marketCap":259588930},{"date":"2023-11-10","current":-2.528539,"twenty":-9.439644,"median":-5.283326,"eighty":-3.2138,"marketCap":169558766},{"date":"2023-11-17","current":-2.463401,"twenty":-9.439644,"median":-5.283326,"eighty":-3.199668,"marketCap":165190742},{"date":"2023-11-24","current":-2.652893,"twenty":-9.439644,"median":-5.283326,"eighty":-3.195033,"marketCap":177897722},{"date":"2023-12-01","current":-2.937132,"twenty":-9.439644,"median":-5.283326,"eighty":-3.187346,"marketCap":196958192},{"date":"2023-12-08","current":-4.405698,"twenty":-9.427719,"median":-5.275885,"eighty":-3.181747,"marketCap":295437288},{"date":"2023-12-15","current":-6.229363,"twenty":-9.427719,"median":-5.291431,"eighty":-3.181747,"marketCap":417728592},{"date":"2023-12-22","current":-6.788197,"twenty":-9.427719,"median":-5.320368,"eighty":-3.187563,"marketCap":455202925},{"date":"2023-12-29","current":-7.429213,"twenty":-9.439644,"median":-5.333345,"eighty":-3.193428,"marketCap":498188189},{"date":"2024-01-05","current":-7.248414,"twenty":-9.451569,"median":-5.343583,"eighty":-3.198707,"marketCap":486064140},{"date":"2024-01-12","current":-7.248414,"twenty":-9.451569,"median":-5.368182,"eighty":-3.206784,"marketCap":486064140},{"date":"2024-01-19","current":-6.459471,"twenty":-9.463494,"median":-5.411826,"eighty":-3.238548,"marketCap":433159200},{"date":"2024-01-26","current":-7.051178,"twenty":-9.451569,"median":-5.44682,"eighty":-3.25699,"marketCap":472837905},{"date":"2024-02-02","current":-8.629064,"twenty":-9.451569,"median":-5.474221,"eighty":-3.281144,"marketCap":578647786},{"date":"2024-02-09","current":-8.267465,"twenty":-9.451569,"median":-5.496861,"eighty":-3.299371,"marketCap":554399688},{"date":"2024-02-16","current":-11.275311,"twenty":-9.64194,"median":-5.528613,"eighty":-3.313041,"marketCap":756099774},{"date":"2024-02-23","current":-15.943223,"twenty":-9.755565,"median":-5.551567,"eighty":-3.33764,"marketCap":1069120672},{"date":"2024-03-01","current":-16.534931,"twenty":-9.849606,"median":-5.569025,"eighty":-3.345816,"marketCap":1108799377},{"date":"2024-03-08","current":-17.044456,"twenty":-9.971199,"median":-5.597312,"eighty":-3.351091,"marketCap":1142967151},{"date":"2024-03-15","current":-17.046796,"twenty":-10.152659,"median":-5.619134,"eighty":-3.365798,"marketCap":1376290085},{"date":"2024-03-22","current":-18.685202,"twenty":-10.301095,"median":-5.654745,"eighty":-3.378916,"marketCap":1508568505},{"date":"2024-03-28","current":-17.138841,"twenty":-10.400002,"median":-5.664545,"eighty":-3.391505,"marketCap":1383721457},{"date":"2024-04-05","current":-15.592479,"twenty":-10.637061,"median":-5.682197,"eighty":-3.403589,"marketCap":1258874408},{"date":"2024-04-12","current":-15.242707,"twenty":-10.969382,"median":-5.713045,"eighty":-3.414089,"marketCap":1230635194},{"date":"2024-04-19","current":-10.787713,"twenty":-11.273007,"median":-5.726028,"eighty":-3.425798,"marketCap":870956792},{"date":"2024-04-26","current":-8.047924,"twenty":-11.270702,"median":-5.742617,"eighty":-3.440231,"marketCap":649757161},{"date":"2024-05-03","current":-11.249554,"twenty":-11.270702,"median":-5.760976,"eighty":-3.454073,"marketCap":908243991},{"date":"2024-05-10","current":-7.847512,"twenty":-11.30986,"median":-5.794665,"eighty":-3.48638,"marketCap":904551263},{"date":"2024-05-17","current":-8.425325,"twenty":-11.30986,"median":-5.820689,"eighty":-3.50045,"marketCap":971153497},{"date":"2024-05-24","current":-7.793761,"twenty":-11.30986,"median":-5.872737,"eighty":-3.519115,"marketCap":898355707},{"date":"2024-05-31","current":-7.659386,"twenty":-11.30986,"median":-5.91611,"eighty":-3.535148,"marketCap":882866815},{"date":"2024-06-07","current":-6.638135,"twenty":-11.30986,"median":-5.968158,"eighty":-3.549802,"marketCap":765151240},{"date":"2024-06-14","current":-7.726574,"twenty":-11.30986,"median":-6.037555,"eighty":-3.564515,"marketCap":890611261},{"date":"2024-06-21","current":-8.39845,"twenty":-11.321376,"median":-6.04623,"eighty":-3.594493,"marketCap":968055718},{"date":"2024-06-28","current":-9.191263,"twenty":-11.321376,"median":-6.065075,"eighty":-3.619852,"marketCap":1059440178},{"date":"2024-07-05","current":-8.962826,"twenty":-11.321376,"median":-6.097628,"eighty":-3.623326,"marketCap":1033109063},{"date":"2024-07-12","current":-10.924704,"twenty":-11.321376,"median":-6.126684,"eighty":-3.623326,"marketCap":1259246878},{"date":"2024-07-19","current":-10.548453,"twenty":-11.331879,"median":-6.15093,"eighty":-3.628327,"marketCap":1215877982},{"date":"2024-07-26","current":-11.327829,"twenty":-11.331879,"median":-6.246513,"eighty":-3.659921,"marketCap":1305713553},{"date":"2024-08-02","current":-10.45439,"twenty":-11.332892,"median":-6.294458,"eighty":-3.694721,"marketCap":1205035758},{"date":"2024-08-09","current":-9.398507,"twenty":-11.332892,"median":-6.363017,"eighty":-3.740471,"marketCap":1300386852},{"date":"2024-08-16","current":-9.139316,"twenty":-11.332892,"median":-6.44211,"eighty":-3.763187,"marketCap":1264524865},{"date":"2024-08-23","current":-10.266235,"twenty":-11.332892,"median":-6.480732,"eighty":-3.788231,"marketCap":1420446550},{"date":"2024-08-30","current":-9.939428,"twenty":-11.332892,"median":-6.557475,"eighty":-3.816724,"marketCap":1375229261},{"date":"2024-09-06","current":-9.454853,"twenty":-11.332892,"median":-6.583321,"eighty":-3.837162,"marketCap":1308182937},{"date":"2024-09-13","current":-10.142274,"twenty":-11.332892,"median":-6.62319,"eighty":-3.850659,"marketCap":1403295165},{"date":"2024-09-20","current":-10.119736,"twenty":-11.332892,"median":-6.65744,"eighty":-3.882597,"marketCap":1400176731},{"date":"2024-09-27","current":-9.78166,"twenty":-11.332892,"median":-6.734976,"eighty":-3.917476,"marketCap":1353400225},{"date":"2024-10-04","current":-11.088886,"twenty":-11.332892,"median":-6.764783,"eighty":-3.936724,"marketCap":1534269380},{"date":"2024-10-11","current":-11.021271,"twenty":-11.332892,"median":-6.804633,"eighty":-3.964491,"marketCap":1524914079},{"date":"2024-10-18","current":-12.767996,"twenty":-11.524097,"median":-6.881776,"eighty":-4.001318,"marketCap":1766592691},{"date":"2024-10-25","current":-12.553881,"twenty":-11.779563,"median":-7.054721,"eighty":-4.046171,"marketCap":1736967570},{"date":"2024-11-01","current":-11.708692,"twenty":-11.959519,"median":-7.112227,"eighty":-4.085278,"marketCap":1620026307},{"date":"2024-11-08","current":-12.508805,"twenty":-12.028902,"median":-7.184646,"eighty":-4.113553,"marketCap":1730730703},{"date":"2024-11-15","current":-8.260457,"twenty":-12.030147,"median":-7.21972,"eighty":-4.156039,"marketCap":1440111631},{"date":"2024-11-22","current":-7.962865,"twenty":-12.030147,"median":-7.248414,"eighty":-4.176445,"marketCap":1388229880},{"date":"2024-11-29","current":-8.918769,"twenty":-12.030147,"median":-7.304401,"eighty":-4.191602,"marketCap":1554880353},{"date":"2024-12-06","current":-8.675284,"twenty":-12.030147,"median":-7.380818,"eighty":-4.240028,"marketCap":1512431647},{"date":"2024-12-13","current":-7.836613,"twenty":-12.030147,"median":-7.426828,"eighty":-4.272191,"marketCap":1366219440},{"date":"2024-12-20","current":-7.665272,"twenty":-12.030147,"median":-7.456187,"eighty":-4.324295,"marketCap":1336348129},{"date":"2024-12-27","current":-7.611164,"twenty":-12.030147,"median":-7.48036,"eighty":-4.36444,"marketCap":1326915083},{"date":"2025-01-03","current":-7.899739,"twenty":-12.030147,"median":-7.5217,"eighty":-4.400624,"marketCap":1377224660},{"date":"2025-01-10","current":-7.403751,"twenty":-12.030147,"median":-7.560704,"eighty":-4.545515,"marketCap":1290755075},{"date":"2025-01-17","current":-7.223391,"twenty":-12.030147,"median":-7.560704,"eighty":-4.60666,"marketCap":1259311590},{"date":"2025-01-24","current":-7.187319,"twenty":-12.030147,"median":-7.560704,"eighty":-4.657209,"marketCap":1253022893},{"date":"2025-01-31","current":-6.943834,"twenty":-12.030147,"median":-7.560704,"eighty":-4.730826,"marketCap":1210574187},{"date":"2025-02-07","current":-6.826601,"twenty":-12.030147,"median":-7.560704,"eighty":-4.771056,"marketCap":1190135922},{"date":"2025-02-14","current":-6.56508,"twenty":-12.030147,"median":-7.560704,"eighty":-4.786157,"marketCap":1144542868},{"date":"2025-02-21","current":-6.312577,"twenty":-12.030147,"median":-7.560704,"eighty":-4.801308,"marketCap":1100521989},{"date":"2025-02-28","current":-6.438828,"twenty":-12.030147,"median":-7.560704,"eighty":-4.840454,"marketCap":1122532428},{"date":"2025-03-07","current":-6.196334,"twenty":-12.049092,"median":-7.565589,"eighty":-4.868603,"marketCap":1199027727},{"date":"2025-03-14","current":-6.344257,"twenty":-12.049092,"median":-7.565589,"eighty":-4.881584,"marketCap":1227651731},{"date":"2025-03-21","current":-6.17168,"twenty":-12.049092,"median":-7.565589,"eighty":-4.903224,"marketCap":1194257059},{"date":"2025-03-28","current":-6.229205,"twenty":-12.049092,"median":-7.565589,"eighty":-4.93505,"marketCap":1205388617},{"date":"2025-04-04","current":-5.222507,"twenty":-12.049092,"median":-7.565589,"eighty":-4.967875,"marketCap":1010586366},{"date":"2025-04-11","current":-5.842962,"twenty":-12.030147,"median":-7.560704,"eighty":-5.007482,"marketCap":1130648161},{"date":"2025-04-17","current":-6.007321,"twenty":-12.030147,"median":-7.560704,"eighty":-5.0244,"marketCap":1162452610},{"date":"2025-04-25","current":-6.346583,"twenty":-12.049092,"median":-7.565589,"eighty":-5.036289,"marketCap":1228101960},{"date":"2025-05-02","current":-7.243831,"twenty":-12.049092,"median":-7.565589,"eighty":-5.07122,"marketCap":1401724676},{"date":"2025-05-09","current":-5.835973,"twenty":-12.049092,"median":-7.565589,"eighty":-5.091019,"marketCap":1124656136},{"date":"2025-05-16","current":-5.968233,"twenty":-12.049092,"median":-7.565589,"eighty":-5.131269,"marketCap":1150144093},{"date":"2025-05-23","current":-5.9641,"twenty":-12.049092,"median":-7.565589,"eighty":-5.152879,"marketCap":1149347595},{"date":"2025-05-30","current":-6.728728,"twenty":-12.049092,"median":-7.565589,"eighty":-5.177397,"marketCap":1296699851},{"date":"2025-06-06","current":-6.993248,"twenty":-12.049092,"median":-7.565589,"eighty":-5.194225,"marketCap":1347675766},{"date":"2025-06-13","current":-7.398294,"twenty":-12.049092,"median":-7.565589,"eighty":-5.221891,"marketCap":1425732637},{"date":"2025-06-20","current":-6.885786,"twenty":-12.068037,"median":-7.570474,"eighty":-5.221891,"marketCap":1326966800},{"date":"2025-06-27","current":-7.819873,"twenty":-12.068037,"median":-7.582689,"eighty":-5.221891,"marketCap":1506975502},{"date":"2025-07-03","current":-7.952133,"twenty":-12.068037,"median":-7.611164,"eighty":-5.221891,"marketCap":1532463460},{"date":"2025-07-11","current":-9.159005,"twenty":-12.068037,"median":-7.6464,"eighty":-5.244103,"marketCap":1765041074},{"date":"2025-07-18","current":-9.406993,"twenty":-12.068037,"median":-7.669116,"eighty":-5.255597,"marketCap":1812830995},{"date":"2025-07-25","current":-9.85337,"twenty":-12.068037,"median":-7.686867,"eighty":-5.255597,"marketCap":1898852853},{"date":"2025-08-01","current":-9.572318,"twenty":-12.068037,"median":-7.709191,"eighty":-5.255597,"marketCap":1844690942},{"date":"2025-08-08","current":-9.873868,"twenty":-12.068037,"median":-7.726574,"eighty":-5.26094,"marketCap":2140141218},{"date":"2025-08-15","current":-10.154832,"twenty":-12.068037,"median":-7.751329,"eighty":-5.309264,"marketCap":2201039545},{"date":"2025-08-22","current":-9.7374,"twenty":-12.068037,"median":-7.788453,"eighty":-5.322711,"marketCap":2110562030},{"date":"2025-08-29","current":-10.050474,"twenty":-12.068037,"median":-7.805928,"eighty":-5.338338,"marketCap":2178420166},{"date":"2025-09-05","current":-10.19497,"twenty":-12.086982,"median":-7.820543,"eighty":-5.359952,"marketCap":2209739306},{"date":"2025-09-12","current":-10.251163,"twenty":-12.068037,"median":-7.837811,"eighty":-5.371996,"marketCap":2221918972},{"date":"2025-09-19","current":-10.202997,"twenty":-12.068037,"median":-7.858017,"eighty":-5.398408,"marketCap":2211479258},{"date":"2025-09-26","current":-9.825703,"twenty":-12.068037,"median":-7.880341,"eighty":-5.452018,"marketCap":2129701505},{"date":"2025-10-03","current":-8.878454,"twenty":-12.068037,"median":-7.902693,"eighty":-5.482121,"marketCap":1924387144},{"date":"2025-10-10","current":-11.673172,"twenty":-12.068037,"median":-7.918018,"eighty":-5.487961,"marketCap":2530136613},{"date":"2025-10-17","current":-11.927361,"twenty":-12.068037,"median":-7.955158,"eighty":-5.487961,"marketCap":2585231715},{"date":"2025-10-24","current":-11.184345,"twenty":-12.068037,"median":-7.968449,"eighty":-5.487961,"marketCap":2424184494},{"date":"2025-10-31","current":-11.555853,"twenty":-12.068037,"median":-8.006843,"eighty":-5.487961,"marketCap":2504708104},{"date":"2025-11-07","current":-9.070643,"twenty":-12.068037,"median":-8.007954,"eighty":-5.487961,"marketCap":2264694627},{"date":"2025-11-14","current":-9.548494,"twenty":-12.068037,"median":-8.007954,"eighty":-5.487961,"marketCap":2384001211},{"date":"2025-11-21","current":-10.000746,"twenty":-12.068037,"median":-8.007954,"eighty":-5.487961,"marketCap":2496916371},{"date":"2025-11-28","current":-10.367668,"twenty":-12.026412,"median":-8.007954,"eighty":-5.487961,"marketCap":2588526784},{"date":"2025-12-05","current":-10.606594,"twenty":-11.934555,"median":-8.007954,"eighty":-5.487961,"marketCap":2648180076},{"date":"2025-12-12","current":-12.517999,"twenty":-11.917867,"median":-8.007954,"eighty":-5.487961,"marketCap":3125406414},{"date":"2025-12-19","current":-11.075912,"twenty":-11.883,"median":-8.007954,"eighty":-5.487961,"marketCap":2765356186},{"date":"2025-12-26","current":-10.845519,"twenty":-11.763536,"median":-8.007954,"eighty":-5.487961,"marketCap":2707833369},{"date":"2026-01-02","current":-10.359135,"twenty":-11.670239,"median":-8.007954,"eighty":-5.487961,"marketCap":2586396310},{"date":"2026-01-09","current":-9.710622,"twenty":-11.575014,"median":-8.007954,"eighty":-5.487961,"marketCap":2424480231},{"date":"2026-01-16","current":-9.625292,"twenty":-11.510881,"median":-8.007954,"eighty":-5.487961,"marketCap":2403175484},{"date":"2026-01-23","current":-9.488763,"twenty":-11.380657,"median":-8.007954,"eighty":-5.487961,"marketCap":2369087888},{"date":"2026-01-30","current":-8.490395,"twenty":-11.306264,"median":-8.007954,"eighty":-5.487961,"marketCap":2119822346},{"date":"2026-02-06","current":-7.293804,"twenty":-11.255248,"median":-7.988048,"eighty":-5.487961,"marketCap":1939707000},{"date":"2026-02-13","current":-7.416315,"twenty":-11.126266,"median":-7.962196,"eighty":-5.487961,"marketCap":1972287517},{"date":"2026-02-20","current":-5.754602,"twenty":-11.080179,"median":-7.952133,"eighty":-5.487961,"marketCap":1530373206},{"date":"2026-02-27","current":-7.850162,"twenty":-10.982374,"median":-7.917548,"eighty":-5.487961,"marketCap":2087664160},{"date":"2026-03-06","current":-8.455909,"twenty":-10.84698,"median":-7.910913,"eighty":-5.487961,"marketCap":2248756077},{"date":"2026-03-13","current":-7.260786,"twenty":-10.827953,"median":-7.902693,"eighty":-5.487961,"marketCap":1930926079},{"date":"2026-03-20","current":-6.769639,"twenty":-10.827953,"median":-7.880341,"eighty":-5.487961,"marketCap":1800311012},{"date":"2026-03-23","current":-6.695967,"twenty":-10.827953,"median":-7.87674,"eighty":-5.487961,"marketCap":1780718752}],"updateTime":1774398450222},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OCUL\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2612451349","title":"Ocular Therapeutix: Axpaxli Met Its Week 52 Durability Assessment With High Statistical Significance","url":"https://stock-news.laohu8.com/highlight/detail?id=2612451349","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612451349?lang=en_us&edition=fundamental","pubTime":"2026-02-17 20:00","pubTimestamp":1771329600,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nP8N3W4076:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","OCUL"],"gpt_icon":0},{"id":"2612341451","title":"Ocular Therapeutix: Superiority Primary Endpoint Met With 74.1% of Subjects in Axpaxli Arm Maintaining Vision at Week 36","url":"https://stock-news.laohu8.com/highlight/detail?id=2612341451","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612341451?lang=en_us&edition=fundamental","pubTime":"2026-02-17 20:00","pubTimestamp":1771329600,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260217:nP8N3W4076:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","OCUL"],"gpt_icon":0},{"id":"2611811913","title":"Assessing Ocular Therapeutix (OCUL) Valuation After Wider Losses And Potential Share Dilution","url":"https://stock-news.laohu8.com/highlight/detail?id=2611811913","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611811913?lang=en_us&edition=fundamental","pubTime":"2026-02-14 15:23","pubTimestamp":1771053803,"startTime":"0","endTime":"0","summary":"Why the latest earnings and share filing matter for Ocular Therapeutix (OCUL)\nOcular Therapeutix (OCUL) just released fourth quarter and full year 2025 results alongside a new shelf registration. Together, these updates put profitability trends and potential share dilution in clear focus for investors.\nFor the fourth quarter, Ocular Therapeutix reported revenue of US$13.25 million compared with US$17.08 million a year earlier. The company posted a net loss of US$64.65 million versus US$48.39...","market":"hk","thumbnail":"https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/6121000-choice1-main-header/1585186685410"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ocul/ocular-therapeutix/news/assessing-ocular-therapeutix-ocul-valuation-after-wider-loss","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-ocul/ocular-therapeutix/news/assessing-ocular-therapeutix-ocul-valuation-after-wider-loss","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["BK4007","OCUL"],"gpt_icon":0},{"id":"2611019692","title":"Ocular Therapeutix to Release Topline Data for Macular Degeneration Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2611019692","media":"Dow Jones","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611019692?lang=en_us&edition=fundamental","pubTime":"2026-02-14 06:30","pubTimestamp":1771021800,"startTime":"0","endTime":"0","summary":"Ocular Therapeutix said it would release topline data from its Phase 3 superiority clinical trial of its Axpaxli treatment of wet age-related macular degeneration on Tuesday.Detailed data will be presented at the Macula Society annual meeting Feb. 25-28.The stock jumped 15% to $10.25 in after-hours trading.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","OCUL"],"gpt_icon":0},{"id":"2611195470","title":"Ocular Therapeutix to Announce Topline Data for Phase 3 SOL-1 Trial in Wet AMD","url":"https://stock-news.laohu8.com/highlight/detail?id=2611195470","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611195470?lang=en_us&edition=fundamental","pubTime":"2026-02-14 06:00","pubTimestamp":1771020025,"startTime":"0","endTime":"0","summary":"Ocular Therapeutix, Inc. announced that it will release topline results from the SOL-1 Phase 3 superiority clinical trial of AXPAXLI , its investigational axitinib intravitreal hydrogel for the treatment of wet age-related macular degeneration , on Tuesday, February 17, 2026. The company will host a webcast to review the results on the same date. Detailed data from the SOL-1 trial will be presented at the 49th Macula Society Annual Meeting, scheduled between February 25 and 28, 2026.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260213:nNDL19hlM5:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","BK4112","BK4585","SG9999014005.SGD","SG9999014013.SGD","LU2210150020.SGD","IE00B3QW5Z07.USD","BK4588","OCUL","LU0314104364.USD","IE00B64PRP62.GBP","NDAQ","IE00BKPKM429.USD","SG9999014021.USD","IE00BGHQF748.EUR","SG9999014039.USD","LU2210149790.SGD","LU2095319765.USD"],"gpt_icon":0},{"id":"2609851187","title":"Ocular Therapeutix gewährt neuen Mitarbeitern Aktienanreize gemäß Nasdaq-Regel","url":"https://stock-news.laohu8.com/highlight/detail?id=2609851187","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609851187?lang=en_us&edition=fundamental","pubTime":"2026-02-07 05:01","pubTimestamp":1770411693,"startTime":"0","endTime":"0","summary":"Ocular Therapeutix Inc. hat die Gewhrung von Aktienoptionen und Restricted Stock Units an fünf neu eingestellte, nicht geschftsführende Mitarbeitende bekannt gegeben. Die Zuteilungen erfolgten am 2. Februar 2026 unter dem 2019 Inducement Stock Incentive Plan. Die Aktienoptionen umfassen insgesamt 13.850 Aktien zum Ausübungspreis von 9,15 US-Dollar pro Aktie mit einer Laufzeit von zehn Jahren und einer vierjhrigen Vesting-Periode. Die Restricted Stock Units betreffen insgesamt 4.600 Aktien und werden über drei Jahre in gleichen jhrlichen Tranchen vergeben, beginnend ab dem 2. Februar 2027.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ocular Therapeutix Inc. published the original content used to generate this news brief via GlobeNewsw","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nNDL70TpD6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B64PRP62.GBP","IE00BKPKM429.USD","LU0314104364.USD","LU2095319765.USD","IE00B3QW5Z07.USD","NDAQ","OCUL","LU2210150020.SGD","BK4588","BK4112","LU2210149790.SGD","SG9999014005.SGD","SG9999014039.USD","BK4585","SG9999014021.USD","IE00BGHQF748.EUR","SG9999014013.SGD","BK4007"],"gpt_icon":0},{"id":"2609151180","title":"Ocular Therapeutix Grants Inducement Equity Awards to New Employees","url":"https://stock-news.laohu8.com/highlight/detail?id=2609151180","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609151180?lang=en_us&edition=fundamental","pubTime":"2026-02-07 05:01","pubTimestamp":1770411693,"startTime":"0","endTime":"0","summary":"Ocular Therapeutix, Inc. has granted inducement equity awards to five newly hired non-executive employees, effective February 2, 2026. The awards include non-statutory stock options to purchase up to a total of 13,850 shares of common stock at an exercise price of $9.15 per share, and restricted stock units representing a total of 4,600 shares. The stock options have a ten-year term and vest over four years, with 25% vesting after one year and the remainder vesting monthly over the following three years. The restricted stock units vest in equal annual installments over three years, starting February 2, 2027.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ocular Therapeutix Inc. published the original content used to generate this news ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260206:nNDLDpYKS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BGHQF748.EUR","BK4007","SG9999014005.SGD","LU2210149790.SGD","SG9999014021.USD","IE00B3QW5Z07.USD","IE00B64PRP62.GBP","SG9999014013.SGD","LU2095319765.USD","LU0314104364.USD","LU2210150020.SGD","BK4588","BK4112","SG9999014039.USD","IE00BKPKM429.USD","OCUL","BK4585","NDAQ"],"gpt_icon":0},{"id":"2609511569","title":"Ocular Therapeutix™ Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)","url":"https://stock-news.laohu8.com/highlight/detail?id=2609511569","media":"GlobeNewswire","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609511569?lang=en_us&edition=fundamental","pubTime":"2026-02-07 05:01","pubTimestamp":1770411660,"startTime":"0","endTime":"0","summary":"BEDFORD, Mass., Feb.  06, 2026  (GLOBE NEWSWIRE) -- Ocular Therapeutix, Inc. (NASDAQ: OCUL, “Ocular”), an integrated biopharmaceutical company committed to redefining the retina experience, today anno","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2026/02/06/3234068/0/en/Ocular-Therapeutix-Reports-Inducement-Grant-Under-Nasdaq-Listing-Rule-5635-c-4.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","OCUL"],"gpt_icon":0},{"id":"2609518059","title":"Analysts Conflicted on These Healthcare Names: Illumina (ILMN) and Ocular Therapeutix (OCUL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2609518059","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609518059?lang=en_us&edition=fundamental","pubTime":"2026-02-07 01:10","pubTimestamp":1770397805,"startTime":"0","endTime":"0","summary":"Analysts have been eager to weigh in on the Healthcare sector with new ratings on Illumina (ILMN – Research Report) and Ocular Therapeutix (OCUL – ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-illumina-ilmn-and-ocular-therapeutix-ocul-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-conflicted-on-these-healthcare-names-illumina-ilmn-and-ocular-therapeutix-ocul-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4535","XBI","HCSG","LABU","BK4534","LU0029874061.USD","LU0128526141.USD","ILMN","BK4137","BK4585","BK4581","OCUL","XLV","BK4548","BK4007","BK4588","BK4121"],"gpt_icon":0},{"id":"2609004556","title":"Regulatory Turbulence Threatens Ocular Therapeutix: FDA Disruptions and Global Delays Raise Approval and Funding Risks","url":"https://stock-news.laohu8.com/highlight/detail?id=2609004556","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609004556?lang=en_us&edition=fundamental","pubTime":"2026-02-06 14:00","pubTimestamp":1770357646,"startTime":"0","endTime":"0","summary":"Ocular Therapeutix Inc (OCUL) has disclosed a new risk, in the Regulation category. Ocular Therapeutix Inc. faces elevated regulatory risk due to d...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/regulatory-turbulence-threatens-ocular-therapeutix-fda-disruptions-and-global-delays-raise-approval-and-funding-risks?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/regulatory-turbulence-threatens-ocular-therapeutix-fda-disruptions-and-global-delays-raise-approval-and-funding-risks?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OCUL","BK4007"],"gpt_icon":0},{"id":"2609585081","title":"Ocular Therapeutix's Recent Stock Weakness Presents Buying Opportunity, RBC Says","url":"https://stock-news.laohu8.com/highlight/detail?id=2609585081","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609585081?lang=en_us&edition=fundamental","pubTime":"2026-02-06 02:22","pubTimestamp":1770315749,"startTime":"0","endTime":"0","summary":"Ocular Therapeutix  shares have declined about 28% year to date, largely reflecting investor caution ahead of the pivotal SOL-1 readout, RBC Capital Markets said in a Wednesday note.The firm said the timing of the SOL-1 data remains within guided timelines and an update was expected during the Q4 earnings call.Ocular Therapeutix said Thursday that it will not be hosting Q4 conference call as it is currently observing a quiet period related to the anticipated data readout.RBC said its internal trial simulations suggest SOL-1 can meet its primary endpoint under a range of scenarios.The firm also pointed to data from the long-acting TKI class as supportive, citing phase 1 results showing 73% patients remained rescue-injection free for up to nine months.RBC highlighted recent corporate actions, including the hiring of a new chief commercial officer with experience in retina, and the launch of two pivotal diabetic retinopathy studies.RBC maintained its outperform rating on Ocular Therapeuti","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OCUL","BK4007"],"gpt_icon":0},{"id":"2609302505","title":"Analysts Offer Insights on Healthcare Companies: Cabaletta Bio (CABA) and Ocular Therapeutix (OCUL)","url":"https://stock-news.laohu8.com/highlight/detail?id=2609302505","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609302505?lang=en_us&edition=fundamental","pubTime":"2026-02-05 23:30","pubTimestamp":1770305415,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Cabaletta Bio (CABA – Research Report) and Ocular Th...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-cabaletta-bio-caba-and-ocular-therapeutix-ocul-blurbs?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-offer-insights-on-healthcare-companies-cabaletta-bio-caba-and-ocular-therapeutix-ocul-blurbs?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","XLV","LU0128526141.USD","HCSG","BK4585","BK4137","LU0029874061.USD","BK4007","LABU","XBI","CABA","BK4139","OCUL","BK4581"],"gpt_icon":0},{"id":"2609372236","title":"Ocular Therapeutix Q4 EPS $(0.29) Beats $(0.32) Estimate, Sales $13.250M Miss $16.128M Estimate","url":"https://stock-news.laohu8.com/highlight/detail?id=2609372236","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609372236?lang=en_us&edition=fundamental","pubTime":"2026-02-05 20:17","pubTimestamp":1770293850,"startTime":"0","endTime":"0","summary":"Ocular Therapeutix (NASDAQ:OCUL) reported quarterly losses of $(0.29) per share which beat the analyst consensus estimate of $(0.32) by 9.66 percent. This is unchanged from the same period last year.  The company","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/02/50406697/ocular-therapeutix-q4-eps-0-29-beats-0-32-estimate-sales-13-250m-miss-16-128m-estimate","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OCUL"],"gpt_icon":0},{"id":"2609372945","title":"Ocular Therapeutix Q4 revenue falls 22.4% yr/yr","url":"https://stock-news.laohu8.com/highlight/detail?id=2609372945","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609372945?lang=en_us&edition=fundamental","pubTime":"2026-02-05 20:10","pubTimestamp":1770293422,"startTime":"0","endTime":"0","summary":"Ocular Therapeutix Q4 revenue falls 22.4% yr/yrOverviewBiopharmaceutical firm's Q4 2025 revenue fell 22.4% yr/yr due to reimbursement challengesNet loss for Q4 2025 widened compared to the same period","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nL1N3Z10MH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","OCUL"],"gpt_icon":0},{"id":"2609372911","title":"Earnings Flash (OCUL) Ocular Therapeutix Posts Q4 Loss $0.29 a Share, vs. FactSet Est of $0.32 Loss","url":"https://stock-news.laohu8.com/highlight/detail?id=2609372911","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609372911?lang=en_us&edition=fundamental","pubTime":"2026-02-05 20:09","pubTimestamp":1770293395,"startTime":"0","endTime":"0","summary":"Earnings Flash (OCUL) Ocular Therapeutix Posts Q4 Loss $0.29 a Share, vs. FactSet Est of $0.32 Loss","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["OCUL"],"gpt_icon":0},{"id":"2609583372","title":"Ocular Therapeutix to Present Phase 3 SOL-1 Wet AMD Trial Results at Macula Society Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2609583372","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609583372?lang=en_us&edition=fundamental","pubTime":"2026-02-05 20:05","pubTimestamp":1770293159,"startTime":"0","endTime":"0","summary":"Ocular Therapeutix Inc. has announced updated timing for the presentation of topline results from the SOL-1 Phase 3 superiority clinical trial of AXPAXLI  for the treatment of wet age-related macular degeneration . The results remain masked and are expected to be presented at the 49th Macula Society Annual Meeting scheduled for February 25–28, 2026. The company also completed randomization of 631 subjects in the SOL-R Phase 3 non-inferiority trial in December 2025, with topline results now anticipated in the first quarter of 2027. Ocular Therapeutix plans to submit a new drug application for AXPAXLI in wet AMD based on the SOL-1 52-week data, pending positive results and planned interactions with the U.S. Food and Drug Administration.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpre","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nNDL7JHQDK:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","OCUL"],"gpt_icon":0},{"id":"2609374052","title":"Ocular Therapeutix Inc. meldet für das Gesamtjahr 2025 einen Anstieg des Eigenkapitals auf 654,31 Mio. USD um 107 Prozent","url":"https://stock-news.laohu8.com/highlight/detail?id=2609374052","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609374052?lang=en_us&edition=fundamental","pubTime":"2026-02-05 20:03","pubTimestamp":1770292997,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Ocular Therapeutix Inc. published the original content used to generate this news brief via GlobeNewswire  on February 05, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nNDL54F7jg:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OCUL","SG9999014039.USD","NDAQ","SG9999014005.SGD","SG9999014021.USD","LU2095319765.USD","BK4112","SG9999014013.SGD","LU0314104364.USD","LU2210149790.SGD","BK4588","BK4585","IE00BKPKM429.USD","IE00BGHQF748.EUR","LU2210150020.SGD","IE00B64PRP62.GBP","BK4007","IE00B3QW5Z07.USD"],"gpt_icon":0},{"id":"2609741193","title":"BRIEF-Ocular Therapeutix Q4 EPS USD -0.29","url":"https://stock-news.laohu8.com/highlight/detail?id=2609741193","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609741193?lang=en_us&edition=fundamental","pubTime":"2026-02-05 20:00","pubTimestamp":1770292848,"startTime":"0","endTime":"0","summary":"BRIEF-Ocular Therapeutix Q4 EPS USD -0.29\n\n\nFeb 05 (Reuters) - Ocular Therapeutix Q4 net income USD -64.654 million.\n\nQ4 product revenue USD 13.25 million","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nPLX580732:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","OCUL"],"gpt_icon":0},{"id":"2609403374","title":"Ocular Therapeutix™ Reports Fourth Quarter and Full Year 2025 Financial Results and Business Highlights","url":"https://stock-news.laohu8.com/highlight/detail?id=2609403374","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609403374?lang=en_us&edition=fundamental","pubTime":"2026-02-05 20:00","pubTimestamp":1770292803,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nTUAZDK5T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","OCUL"],"gpt_icon":0},{"id":"2609374472","title":"Ocular Therapeutix Q4 Product Revenue USD 13.25 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2609374472","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609374472?lang=en_us&edition=fundamental","pubTime":"2026-02-05 20:00","pubTimestamp":1770292803,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nPLX580732:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OCUL","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":3,"totalSize":143,"code":"91000000","status":"200"}]}}